19 Citations (Scopus)

Abstract

Induced pluripotent stem cell-derived cerebral organoids are an innovative human model of the brain that could improve translation of gene therapy to the clinic. Depla et al. demonstrate the application of cerebral organoids as a preclinical model for AAV capsid selection and testing efficacy of therapeutic transgenes.

Original languageEnglish
Pages (from-to)167-175
Number of pages9
JournalMolecular Therapy - Methods and Clinical Development
Volume18
Early online date1 Jun 2020
DOIs
Publication statusPublished - 11 Sept 2020

Keywords

  • AAV
  • CNS
  • Cerebral organoids
  • SCA3
  • Transduction
  • adeno-associated virus
  • central nervous system
  • gene therapy
  • iPSC
  • induced pluripotent stem cells
  • miRNA
  • micro RNA
  • organoids
  • spinocerebellar ataxia 3

Cite this